| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LANSOPRAZOLE | 7 | |
| Shellac | INACTIVE INGREDIENT | 46N107B71O | PANTOPRAZOLE SODIUM | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Indomethacin Capsules USP, 25 mg and 50 mg | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Indomethacin Extended – Release Capsules, USP 75 mg | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | c635af0d-b005-4bce-8c43-24d0508c28ad | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 1989 | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use PANTOPRAZOLE sodium delayed-release tablets, USP safely and effectively. See full prescribing information for PANTOPRAZOLE sodium delayed-release tablets, USP. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral administration Initial U.S. approval: 2000 | 11 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use OMEPRAZOLE delayed-release capsules, USP safely and effectively. See full prescribing information for OMEPRAZOLE delayed-release capsules, USP . OMEPRAZOLE Delayed-Release Capsules, USP , for oral use INITIAL U.S. APPROVAL: 1989 | 15 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES USP 7384 7385 7386 Rx only | 7 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 1987 | 4 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use amlodipine besylate and benazepril hydrochloride capsules safely and effectively. See full prescribing information for amlodipine besylate and benazepril hydrochloride capsules. AMLODIPINE besylate and BENAZEPRIL hydrochloride capsules for oral use Initial U.S. Approval: 1995 | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use Omeprazole delayed-release capsules safely and effectively. See full prescribing information for Omeprazole delayed-release capsules. OMEPRAZOLE delayed-release capsules, USP, for oral use Initial U.S. Approval: 1989 | 23 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use fluoxetine capsules, USP safely and effectively. See full prescribing information for fluoxetine capsules, USP. FLUOXETINE Capsules, USP for Oral Use Initial U.S. Approval: 1987 | 15 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | GABAPENTIN CAPSULES, USP Rx only | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CLARAVIS™ (isotretinoin capsules USP) | 4 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Terazosin Hydrochloride Capsules | 6 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7384 7385 7386 Rx only | 6 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use phentermine hydrochloride tablets USP safely and effectively. See full prescribing information for phentermine hydrochloride tablets USP. PHENTERMINE Hydrochloride Tablets USP CIV for oral use Initial U.S. Approval: 1959 | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | b3180408-a3c0-4e02-8535-dea390a52277 | 7 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Triamterene and Hydrochlorothiazide Capsules, USP | 6 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Chlorpromazine Hydrochloride Tablets, USP | 4 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use Amlodipine Besylate and Benazepril Hydrochloride Capsules safely and effectively. See full prescribing information for Amlodipine Besylate and Benazepril Hydrochloride Capsules. Amlodipine Besylate and Benazepril Hydrochloride Capsules Initial U.S. Approval: 1995 | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CV LYRICA (pregabalin) Oral Solution, CV Initial U.S. Approval: 2004 | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Amoxicillin Capsules, Tablets and Powder for Oral Suspension, USP | 6 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use lansoprazole delayed-release capsules USP safely and effectively. See full prescribing information for lansoprazole delayed-release capsules USP. LANSOPRAZOLE delayed-release capsules USP for oral use Initial U.S. Approval: 1995 | 4 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Lithium Carbonate Capsules USP Rx Only | 6 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use fluoxetine capsules USP safely and effectively. See full prescribing information for fluoxetine capsules USP. Initial U.S. Approval: 1987 | 9 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Strazepam | 17 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Fluoxetine 10 mg These highlights do not include all the information needed to use fluoxetine capsules USP safely and effectively. See full prescribing information for fluoxetine capsules USP. Initial U.S. Approval: 1987 | 9 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | Fluoxetine 10 mg These highlights do not include all the information needed to use fluoxetine capsules USP safely and effectively. See full prescribing information for fluoxetine capsules USP. Initial U.S. Approval: 1987 | 8 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | HYDROXYZINE PAMOATE Capsules USP | 5 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | AMOXICILLIN CAPSULES USP, 250 mg and 500 mg/ AMOXICILLIN FOR ORAL SUSPENSION USP, 125 mg per 5 mL and 250 mg per 5 mL/AMOXICILLIN TABLETS USP (CHEWABLE), 125 mg and 250 mg 3107 3109 2267 2268 4150 4155 Rx only | 10 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | These highlights do not include all the information needed to use Calcium Acetate Capsules safely and effectively. See full prescribing information for Calcium Acetate Capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 1990 | 7 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY, DBA QUALITY CARE PRODUCTS, LLC] | 3996 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DIVALPROEX SODIUM DR (DIVALPROEX SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3983 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | FLUOXETINE (FLUOXETINE HYDROCHLORIDE) CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3978 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | TEMAZEPAM CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3945 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | NITROFURANTOIN (MACROCRYSTALS) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3922 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | INDOMETHACIN CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3911 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | MEXILETINE HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3749 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DICLOFENAC SODIUM DELAYED RELEASE (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3744 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | OMEPRAZOLE CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3741 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | NITROFURANTOIN MACROCRYSTALS CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3740 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3724 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3671 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | ETODOLAC CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALTIY CARE PRODUCTS LLC] | 3619 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3616 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TEMAZEPAM CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3561 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3544 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3535 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | INDOMETHACIN CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3369 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3363 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3362 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | INDOMETHACIN CAPSULE, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3231 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TRAMADOL HYDROCHLORIDE (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE TRAMADOL HYDROCHLORIDE (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3040 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | FLUOXETINE (FLUOXETINE HYDROCHLORIDE) CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3024 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DIVALPROEX SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1005 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1002 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | NITROFURANTOIN MACROCRYSTALS CAPSULE [BRYANT RANCH PREPACK] | 1002 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TRAMADOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1002 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE) CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | ENTERIC COATED STIMULANT LAXATIVE (BISACODYL) TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LOPERAMIDE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | NORTRIPTYLINE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1001 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | AFEDITAB CR (NIFEDIPINE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DULOXETINE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | GLIPIZIDE ER (GLIPIZIDE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, SUGAR COATED [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | KADIAN (MORPHINE SULFATE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LORATADINE AND PSEUDOEPHEDRINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | NASAL DECONGESTANT (PSEUDOEPHEDRINE HCL) TABLET, SUGAR COATED [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | PHENTERMINE HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | PHENTERMINE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | PHENYTOIN SODIUM CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VERAPAMIL HYDROCHLORIDE CAPSULE, DELAYED RELEASE PELLETS [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VERELAN PM (VERAPAMIL HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ] | 166 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | FLUOXETINE HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ] | 162 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ] | 155 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CHLORPROMAZINE HYDROCHLORIDE TABLET, SUGAR COATED [REMEDYREPACK INC. ] | 151 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CHLORPROMAZINE HYDROCHLORIDE TABLET, SUGAR COATED [REMEDYREPACK INC. ] | 150 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE) CAPSULE [REMEDYREPACK INC. ] | 145 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE) CAPSULE [REMEDYREPACK INC. ] | 126 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | INDOMETHACIN (INDOMETHACIN) CAPSULE [REMEDYREPACK INC. ] | 125 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CALCIUM ACETATE (CALCIUM ACETATE) CAPSULE [REMEDYREPACK INC. ] | 79 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TERAZOSIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC. ] | 77 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 36 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | VICTRELIS (BOCEPREVIR) CAPSULE [MERCK SHARP & DOHME CORP.] | 33 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | ITRACONAZOLE CAPSULE [EON LABS, INC.] | 32 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [ACTAVIS PHARMA, INC.] | 31 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 31 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 28 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | GABAPENTIN CAPSULE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 27 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | CELLCEPT (MYCOPHENOLATE MOFETIL) TABLET, FILM COATED CELLCEPT (MYCOPHENOLATE MOFETIL) CAPSULE CELLCEPT (MYCOPHENOLATE MOFETIL HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION CELLCEPT (MYCOPHENOLATE MOFETIL) POWDER, FOR SUSPENSION [GENENTECH, INC.] | 26 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 25 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | OMEPRAZOLE CAPSULE, DELAYED RELEASE [KREMERS URBAN PHARMACEUTICALS INC.] | 23 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CEPHALEXIN (CEPHALEXIN) CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 22 | |
| Shellac | INACTIVE INGREDIENT | 46N107B71O | CHLORPROMAZINE HYDROCHLORIDE TABLET [REMEDYREPACK INC. ] | 22 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LYRICA (PREGABALIN) CAPSULE LYRICA (PREGABALIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] | 22 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | REYATAZ (ATAZANAVIR) CAPSULE, GELATIN COATED REYATAZ (ATAZANAVIR) POWDER [E.R. SQUIBB & SONS, L.L.C.] | 22 | |
| shellac | INACTIVE INGREDIENT | 46N107B71O | TEMODAR (TEMOZOLOMIDE) CAPSULE TEMODAR (TEMOZOLOMIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 22 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CEPHALEXIN CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 21 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 21 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | REBETOL (RIBAVIRIN) CAPSULE REBETOL (RIBAVIRIN) LIQUID [MERCK SHARP & DOHME CORP.] | 21 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | XALKORI (CRIZOTINIB) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC] | 21 | |